Skip to content

The effect of sarcopenia on prognosis of patients with stage ?B-?A cervical cancer treated with radiotherapy and chemotherapy

The effect of sarcopenia on prognosis of patients with stage ?B-?A cervical cancer treated with radiotherapy and chemotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073586
Enrollment
Unknown
Registered
2023-07-14
Start date
2022-12-13
Completion date
Unknown
Last updated
2023-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia, Cervical cancer

Interventions

Sarcopenia group:None
Nonsarcopenia group:None

Sponsors

Shengjing Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
27 Years to 74 Years

Inclusion criteria

Inclusion criteria: 1) Clinical diagnosis of cervical cancer FIGO?B-IVA stage; 2) Receiving radiotherapy and chemotherapy; 3) The PACS system has complete CT and MRI image data, including L3 axial CT image

Exclusion criteria

Exclusion criteria: 1) Pathological diagnosis of non-primary cervical cancer; 2) Patients with other systemic tumors, autoimmune diseases and other diseases that may affect the results; 3) Patients who did not receive chemoradiotherapy or only received radiotherapy or chemotherapy; 4) Patients with incomplete CT image data; 5) Contraindications of radiotherapy and chemotherapy with abnormal heart, liver and kidney function; 6) Received drugs that affect body composition, such as hormones.

Design outcomes

Primary

MeasureTime frame
Skeletal muscle area;

Secondary

MeasureTime frame
Basic information of the patient (age, height, weight);Patient's tumor characteristics (tumor size, FIGO stage, pathological type, SCC value, etc.);Types of chemotherapy drugs for patients;Patient's blood indicators (white blood cells, hemoglobin, albumin, neutrophil count, lymphocyte count, neutrophil to lymphocyte ratio, monocyte, platelet to lymphocyte ratio, etc.);

Countries

China

Contacts

Public ContactShinong Pan

Shengjing Hospital of China Medical University

18940256901@vip.163.com+86 189 4025 6901

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026